As the number of multinational clinical trials has grown over the past two decades, another type of revolution has been taking place – namely the rapid development and adoption of translation technology, such as computer-assisted and machine translation. What do these new tools mean for pharma?
This article is taken from European Pharmaceutical Contractor May 2016, pages 8-13. © Samedan Ltd. The full issue can be viewed here